Researchers are saying that, from an infection control perspective, C. auris acts more like a multidrug-resistant, healthcare-associated bacteria than like a typical yeast, according to an article on the MedPage website.
"It is a new bug using old tricks mastered by some well-known, multidrug resistant organisms," they said.
Identifying, treating, and preventing Candida auris is a challenge facing more and more healthcare settings.
Findings presented at the 2019 ASM Microbe meeting in San Francisco by researchers from the Centers for Disease Control and Prevention found that patients with C. auris appear to "shed" the pathogen from their skin into their environment, which could potentially play a factor in transmission.
UF Health Hospitals Rely on Green Globes to Realize Their Full Potential
How Healthcare Facilities Can Be Truly Disaster-Resilient
TriasMD Breaks Ground on DISC Surgery Center for San Fernando Valley
Bigfork Valley Hospital Falls Victim to Data Breach
AI-Driven Facilities: Strategic Planning and Cost Management